发明授权
![3-Methyl-imidazo[1,2-b]pyridazine derivatives](/docs/US/2014-09-02/US08822468B2/abs.jpg.600x600.jpg)
- 专利标题： 3-Methyl-imidazo[1,2-b]pyridazine derivatives
- 专利标题（中）： 3-甲基 - 咪唑并[1,2-b]哒嗪衍生物
-
申请号： US12396137申请日： 2009-03-02
-
公开(公告)号： US08822468B2公开(公告)日： 2014-09-02
- 发明人: Pascal Furet , Clive McCarthy , Joseph Schoepfer , Carsten Spanka , Melanie Stang , Frederic Stauffer
- 申请人： Pascal Furet , Clive McCarthy , Joseph Schoepfer , Carsten Spanka , Melanie Stang , Frederic Stauffer
- 申请人地址： CH Basel
- 专利权人： Novartis AG
- 当前专利权人： Novartis AG
- 当前专利权人地址： CH Basel
- 代理商 Qian Zhang
- 优先权： EP08152068 20080228
- 主分类号： C07D519/00
- IPC分类号： C07D519/00 ; C07D487/04 ; A61K31/5025 ; A61P35/00
![3-Methyl-imidazo[1,2-b]pyridazine derivatives](/abs-image/US/2014/09/02/US08822468B2/abs.jpg.150x150.jpg)
摘要：
The invention relates to compounds of formula (I) and salts thereof wherein the substituents are as defined in the specification, the application of a compound of formula (I) in a process for the treatment of the human or animal body, in particular with regard to C-Met tyrosine kinase mediated disease; the use of a compound of formula (I) for manufacturing a medicament for the treatment of such diseases; pharmaceutical compositions comprising a compound of the formula (I), optionally in the presence of a combination partner; processes for the preparation of a compound of formula (I).
公开/授权文献
- US20090264406A1 3-METHYL-IMIDAZO[1,2-B]PYRIDAZINE DERIVATIVES 公开/授权日：2009-10-22